Use of EGF to inhibit pathogenic infections
AssigneeUniversity Technologies International Inc.
InventorsAndre G. Buret, D. Grant Gall, Merle E. Olson, James A. Hardin
Life of this patent
Estimating the term…
Abstract
This invention relates to treating or preventing pathogenic infections with an epidermal growth factor (EGF). EGF is capable of inhibiting pathogenic colonization of pathogens in a variety of tissue or cell types. Since pathogenic colonization is essential for pathogenic infection, EGF can be used as an effective preventive and therapeutic agent for pathogenic infections, particularly in the urogenital tract.
Claims14
A method of inhibiting or treating a pathogenic infection in the urogenital tract of an animal, comprising administering an effective amount of an epidermal growth factor (EGF) to the animal.
Dependencies are inferred from the claim text.